Abstract
This clinical study validates an early treatment window for predicting complete or near-complete pathological response of breast cancer patients based on pretreatment total-hemoglobin level (THb), early changes of THb and ultrasound measurements following neoadjuvant chemotherapy.
© 2020 The Author(s)
PDF Article | Presentation VideoMore Like This
Quing Zhu, Susan Tannenbaum, Scott H. Kurtzman, Patricia DeFusco, Andrew Ricci, Hamed Vavadi, Feifei Zhou, Chen Xu, Alex Merkulov, Poornima Hegde, Mark Kane, Liqun Wang, and Kert Sabbath
OTh4D.2 Optical Tomography and Spectroscopy (OT&S) 2018
Quing Zhu, Patricia DeFusco, Andrew Ricci, Edward Cronin, Poornima Hegde, Mark Kane, Behnoosh Tavakoli, Yan Xu, Jesse Hart, and Susan Tannenbaum
JM3A.70 Biomedical Optics (BIOMED) 2012
Jacqueline E. Gunther, Emerson Lim, Hyun Keol Kim, Molly Flexman, Susan Refice, Mindy Brown, Kevin Kalinsky, Dawn Hershman, and Andreas H. Hielscher
87990P European Conference on Biomedical Optics (ECBO) 2013